UPEXI, INC. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by UPEXI, INC. (UPXI) on February 4, 2026, covering events occurring on January 30, 2026. The Company, a Delaware corporation headquartered in Tampa, Florida, is an emerging growth company with common stock traded on the NASDAQ.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The report focuses exclusively on a corporate transaction.
Material Changes and Agreements
On January 30, 2026, the Company entered into a Common Stock Sales Agreement (the "Sales Agreement") with A.G.P./Alliance Global Partners (the "Sales Agent"). Key terms include:
- Offering Type: An "at-the-market" (ATM) offering allowing the Company to sell shares of common stock from time to time.
- Commission: The Company agreed to pay the Sales Agent a commission of 3.0% of the aggregate gross proceeds from each sale.
- Registration: Sales will be made pursuant to a shelf Registration Statement on Form S-3 (File No. 333-292366), which was declared effective on January 8, 2026. A prospectus supplement was filed on February 4, 2026.
- Sale Methods: Sales may occur directly on The Nasdaq Stock Market LLC, through market makers, or via privately negotiated transactions with prior written consent.
Guidance, Outlook, and Risks
The filing does not provide specific financial guidance, outlook, or management commentary regarding future earnings. The primary contingency noted is the execution of the Sales Agreement, which grants the Company flexibility to raise capital but involves a 3.0% cost on proceeds. The text of the Sales Agreement is incorporated by reference as Exhibit 1.1.
Investor Verification Checklist
- Verify the current share count and potential dilution impact of future ATM sales.
- Review the full text of the Common Stock Sales Agreement (Exhibit 1.1) for specific termination rights and volume limitations.
- Monitor subsequent filings for actual sales volumes and proceeds generated under the ATM program.
- Confirm the status of the Form S-3 Registration Statement (File No. 333-292366) for any amendments or restrictions.